I will say this because I see an opportunity to raise it here, even though it's not within the scope of the BIA.
Since we are hearing from Mr. Yalkin at Health Canada, there were concerns raised about true copy in the deliberations that we had two weeks ago. Again, I know that's not within the scope of the BIA, but there were serious concerns around the table about the issue.
I have 3M in London, Ontario, which employs hundreds of people; it's a pillar of our economy locally. I simply hope that those conversations continue and I hope Health Canada listens to the issues raised.